18 results
6-K
EX-99.3
GLPG
Galapagos NV
11 Apr 22
Current report (foreign)
5:14pm
management by CEO
Current composition of supervisory board 75% independence, 4 different nationalities, 50% female, median tenure of 3.5 years Supervisory … committee 100% independence, 3 different nationalities, 66.7% female, median tenure of 8 years Nomination/ remuneration committee member Position
6-K
EX-99.4
GLPG
Galapagos NV
1 Apr 19
Current report (foreign)
12:00am
recently as Executive Vice President Diabetes & Cardiovascular Global Business Unit. During his tenure at Sanofi, he held many senior positions
6-K
EX-99.1
GLPG
Galapagos NV
1 Apr 19
Current report (foreign)
12:00am
& Cardiovascular Global Business Unit. During his tenure at Sanofi, he held many senior positions including Vice President Eastern Europe & Northern Europe, Vice
6-K
EX-99.1
GLPG
Galapagos NV
2 May 23
Galapagos announces departure of Bart Filius, Chief Operating Officer and Chief Financial Officer
4:49pm
significant contributions and achievements. During his tenure, Bart managed the substantial growth and financing of the company, including the IPO on Nasdaq
6-K
EX-99.1
GLPG
Galapagos NV
15 Jun 23
Galapagos appoints Thad Huston as Chief Financial Officer and Chief Operating Officer
5:03pm
financial roles at various J&J locations in the US, China, Belgium, Russia, and Hungary. During his tenure at J&J, he helped establish the R&D
6-K
EX-99.1
xig 7lt6u7q
13 Jun 23
Galapagos appoints Dr. Susanne Schaffert as non-executive independent Director to its Board
7:53am
6-K
EX-99.2
5mb80ayx7dc599z
11 Apr 22
Current report (foreign)
5:14pm
6-K
EX-99.1
7b6qnys xre0lo
24 Feb 22
Galapagos 2021 results set stage for future growth
5:19pm
6-K
EX-99.15
1okehin ezpso8
29 Mar 24
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings
5:03pm
6-K
EX-99.2
nnwjwlx
4 Aug 23
Galapagos announces first half-year 2023 financial results
4:05pm
6-K
EX-99.2
o39ctyh fr
29 Mar 24
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings
5:03pm
DRS
EX-10
9cq9p0
6 Feb 15
Draft registration statement
12:00am
- Prev
- 1
- Next